England's National Institute for Health and Clinical Excellence (NICE) has reversed an earlier decision to cut back on government subsidies for free treatment of wet Age-Related Macular Degeneration (ARMD). The cutbacks caused much outcry in the country. State provisions for the expensive treatment will now cover 14 injections of Lucentis ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.